Botulinum Toxin Neurotoxins
•1 stocks
•
Total Market Cap: Loading...
Jan 09, 2026
|
Evolus Reports Q4 2025 Profitability and Strong Full‑Year Results, Raises 2026 Guidance
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1)
| Company | Market Cap | Price |
|---|---|---|
|
EOLS
Evolus, Inc.
Evolus directly produces botulinum toxin type A product (Jeuveau) used for cosmetic neuromodulation, a core injectable aesthetic treatment.
|
$365.47M |
$5.50
-4.09%
|
Loading company comparison...
Loading industry trends...
Loading research report...
